Stocks rebound while cryptocurrencies dip on ETF fatigue
Those expecting a run up in bitcoin’s price as spot bitcoin ETFs hit the market last week have been disappointed, but continued interest in the product should only be an upside, analysts say
Cryptocurrency prices slipped while equities recovered Thursday afternoon, led by a rally in tech stocks.
Bitcoin was trading more than 4% lower Thursday over 24 hours, dipping below $41,000 for the first time in a month. If the cryptocurrency cannot rebound to $41,250, it will mark the lowest daily close since Dec. 11. Ether ( ETH ) was also down about 4% Thursday, hovering around $2,430, a low for the past seven days.
Those expecting a run up in bitcoin’s ( BTC ) price as spot bitcoin ETFs hit the d39961b9-1f1e-4bf1-9ad0-f54d4950f0cf last week have been disappointed. Bitcoin is now down more than 11% since the product’s first trading day. And, while spot bitcoin ETFs raked in net inflows of more than $1.2 billion in just four days, bitcoin trading volume on exchanges is on the decline, according to data from Bloomberg.
Analysts say there are a few reasons why what is generally accepted as a successful bitcoin ETF launch has not translated into the price of the cryptocurrency. There has been some “sell the news” action, Noelle Acheson, author of the “Crypto is Macro Now” newsletter, said.
“We’re also seeing some rotation out of BTC into ETH, which has arguably been lagging behind and could be the next beneficiary of ETF speculation,” Acheson added. “This can be seen in the sharp drop in the BTC/ETH ratio.”
Bitcoin ETFs became the second-largest ETF commodity in the US behind gold, showing that interest is strong and will only continue to grow for the asset class , Jag Kooner, Bitfinex Head of Derivatives, said.
In stocks, growing skepticism that the Federal Reserve is in any hurry to cut rates had markets pulling back this week, but strong earnings reports, especially from the tech sector, are helping shares recover. The central bank’s Beige Book, released Wednesday, reported signs of a cooling labor market and relatively flat economic activity.
The SP 500 was up 0.9% while the Nasdaq Composite gained 1.4% Thursday, pushing both back into the green year-to-date after a rocky start to 2024. Analysts say the dip was expectedly short lived as investors digest the news that a soft landing is a real possibility.
“Markets are currently navigating the tension between wanting to see lower interest rates and looking forward to a year when public company profitability finally improves,” Nicolas Colas, co-founder of DataTrek Research, said. “That is a healthy and common mid-cycle market narrative, not something which should engender caution or outright pessimism.”
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
U.S. non-farm payrolls surge by 165,000 in October, far exceeding expectations! Unemployment rate unexpectedly drops to 4.1%, December rate hike expectations intensify
In October, US non-farm payrolls increased by 165,000, which is 2.5 times the Wall Street median forecast of 65,000 and represents an exceptionally strong deviation of about 5 standard deviations, exceeding the upper limit of all institutional forecast ranges. The unemployment rate unexpectedly fell from 4.2% to 4.1%, while the market had expected it to remain unchanged; average hourly wages also accelerated year-on-year growth to 3.1%. Meanwhile, the previous two months' non-farm payrolls were revised upwards by a total of 84,000. Following the release of the data, the yield on 2-year US Treasury bonds rose by 7 basis points, and the pricing of the probability of a Fed rate hike in December climbed to 70%.
AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion
The valuation range discussed by potential investors has been lowered from the previous high of $2 trillion to between $1.2 trillion and $1.3 trillion, and some strategists have even suggested going below $1 trillion to ensure safety. In the face of significant market volatility and financial concerns such as quarterly losses, Anthropic is facing tough decisions, including a discounted valuation, reducing the size of the offering, or postponing the listing.
Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight
Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.
Crypto prices
More
